Automated tumor analysis for molecular profiling in lung cancer
暂无分享,去创建一个
Yinhai Wang | James Diamond | David P. Boyle | Darragh G. McArt | Manuel Salto-Tellez | Perry Maxwell | Peter Bankhead | David McCleary | Jacqueline A. James | M. Salto‐Tellez | P. Maxwell | P. Hamilton | P. Bankhead | David F. McCleary | D. McArt | D. Boyle | Yinhai Wang | J. James | P. Kelly | J. Diamond | Peter W. Hamilton | M. Loughrey | Clinton Boyd | Maurice B. Loughrey | Joseph P. Hougton | Paul Kelly | Jonathon Tunstall | Clinton Boyd | J. Hougton | Jonathon Tunstall
[1] James Diamond,et al. The use of morphological characteristics and texture analysis in the identification of tissue composition in prostatic neoplasia. , 2004, Human pathology.
[2] A. Ruifrok,et al. Quantification of histochemical staining by color deconvolution. , 2001, Analytical and quantitative cytology and histology.
[3] Anant Madabhushi,et al. Automated grading of breast cancer histopathology using spectral clustering with textural and architectural image features , 2008, 2008 5th IEEE International Symposium on Biomedical Imaging: From Nano to Macro.
[4] Wilhelm Burger,et al. Digital Image Processing - An Algorithmic Introduction using Java , 2008, Texts in Computer Science.
[5] M. Salto‐Tellez,et al. Digital pathology and image analysis in tissue biomarker research. , 2014, Methods.
[6] H. Aburatani,et al. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer , 2007, Nature.
[7] David L Rimm,et al. A prospective, multi-institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cells. , 2013, Archives of pathology & laboratory medicine.
[8] Steven J. M. Jones,et al. A new frontier in personalized cancer therapy: mapping molecular changes. , 2011, Future oncology.
[9] T. Mok,et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. , 2009, The New England journal of medicine.
[10] J. Minna,et al. Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. , 2005, Cancer research.
[11] Calum MacAulay,et al. A Java application for tissue section image analysis , 2005, Comput. Methods Programs Biomed..
[12] M. Moasser,et al. Targeting HER proteins in cancer therapy and the role of the non-target HER3 , 2007, British Journal of Cancer.
[13] J. Minna,et al. Targeted Therapies for Lung Cancer: Clinical Experience and Novel Agents , 2011, Cancer journal.
[14] B. Yener,et al. Cell-Graph Mining for Breast Tissue Modeling and Classification , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[15] Kevin W. Bowyer,et al. Evaluation of Texture Segmentation Algorithms , 1999, CVPR.
[16] M. Ostland,et al. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] S. Gabriel,et al. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.
[18] Roy S Herbst,et al. KRAS Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer , 2007, Clinical Cancer Research.
[19] Yinhai Wang,et al. Virtual microscopy and digital pathology in training and education , 2012, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[20] Joon-Oh Park,et al. MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling , 2007, Science.
[21] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[22] A. Ganti,et al. EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab , 2009, Biologics : targets & therapy.
[23] Howard Rosenbaum,et al. Effects of reading proficiency on embedded stem priming in primary school children , 2021 .
[24] Corinna Cortes,et al. Support-Vector Networks , 1995, Machine Learning.
[25] N. Rajpoot,et al. Hyperspectral Colon Tissue Classification using Morphological Analysis , 2006, 2006 International Conference on Emerging Technologies.
[26] E. Brambilla,et al. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF‐R1‐Flt1 and VEGF‐R2‐Flk1/KDR) in non‐small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival , 1999, The Journal of pathology.
[27] F. Cappuzzo,et al. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[28] Mari Mino-Kenudson,et al. Whole-slide imaging digital pathology as a platform for teleconsultation: a pilot study using paired subspecialist correlations. , 2009, Archives of pathology & laboratory medicine.
[29] Mikhail Teverovskiy,et al. Multifeature Prostate Cancer Diagnosis and Gleason Grading of Histological Images , 2007, IEEE Transactions on Medical Imaging.
[30] Danny Crookes,et al. Assisted Diagnosis of Cervical Intraepithelial Neoplasia (CIN) , 2009, IEEE Journal of Selected Topics in Signal Processing.
[31] J. Taube,et al. Tumor Cellularity as a Quality Assurance Measure for Accurate Clinical Detection of BRAF Mutations in Melanoma , 2014, Molecular Diagnosis & Therapy.
[32] Nello Cristianini,et al. An introduction to Support Vector Machines , 2000 .
[33] Declan Kieran,et al. PICan: An integromics framework for dynamic cancer biomarker discovery , 2015, Molecular oncology.
[34] Vincent Mangematin,et al. The future of drug discovery and development: Shifting emphasis towards personalized medicine , 2010 .
[35] Ara Darzi,et al. Preparing for precision medicine. , 2012, The New England journal of medicine.
[36] M. Hidalgo,et al. A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and Immunohistochemistry , 2012, PloS one.
[37] Arivazhagan Selvaraj,et al. Texture segmentation using wavelet transform , 2003, Pattern Recognit. Lett..
[38] Stefan M Willems,et al. The estimation of tumor cell percentage for molecular testing by pathologists is not accurate , 2014, Modern Pathology.
[39] F. Cappuzzo,et al. Gefitinib in pretreated non-small-cell lung cancer (NSCLC): analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced or metastatic NSCLC. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] J. Minna,et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. , 2006, Cancer cell.
[41] Claus Bahlmann,et al. Computer-aided gleason grading of prostate cancer histopathological images using texton forests , 2010, 2010 IEEE International Symposium on Biomedical Imaging: From Nano to Macro.
[42] William Pao,et al. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer , 2010, Nature Reviews Cancer.
[43] Deborah B. Thompson,et al. AUTOMATED LOCATION OF DYSPLASTIC FIELDS IN COLORECTAL HISTOLOGY USING IMAGE TEXTURE ANALYSIS , 1997, The Journal of pathology.
[44] Ravi Salgia,et al. Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer. , 2005, Cancer research.